Pharma among top-paid Indian execs; Teva gets FDA nod for one-dose Plan B;

> Pharma execs are among the highest paid in India, with three of the seven highest-paid executives hailing from Ranbaxy Laboratories, Dr Reddy's Labs and Piramal Healthcare. Report

> Teva Pharmaceutical industries won FDA approval for a one-dose form of the emergency contraceptive Plan B. Report

> Danish drugmaker Novo Nordisk is facing accusations by Swedish authorities that it treated hospital staff to an all-expenses-paid conference trip to South Africa, which if proven could lead to bribery charges. Report

> Par Pharmaceutical got the tentative FDA nod for its version of once-daily Tramadol, but patent disputes remain between Par, Purdue Pharma and Biovail, which make branded forms of the drug. Report

> Medtronic recalled specific lots of its Paradigm Quick Set infusion sets used with Minimed Paradign insulin pumps because they may not work properly. Report

> Sanofi-Aventis has recalled three cough mixtures for babies and children in France after traces of a toxic substance were discovered in a bottle, the French health authority said. Report

> Elan plans to delist from the London Stock Exchange due to low volumes but retain its primary Dublin listing and a presence on the New York Stock Exchange. Report

And Finally... Omega-3 fatty acid supplements did nothing to slow memory declines in people with mild to moderate Alzheimer's, but a study in healthy people with slight memory complaints did show promise. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.